Part I: Vaccines for solid tumours

This publication has 66 references indexed in Scilit:

• Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®
  Seminars in Cancer Biology, 2003
• Natural selection of tumor variants in the generation of “tumor escape” phenotypes
  Nature Immunology, 2002
• Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma
  The Journal of Experimental Medicine, 2002
• Rapid Induction of Tumor-specific Type 1 T Helper Cells in Metastatic Melanoma Patients by Vaccination with Mature, Cryopreserved, Peptide-loaded Monocyte-derived Dendritic Cells
  The Journal of Experimental Medicine, 2002
• CpG Motifs in Bacterial DNA and Their Immune Effects
  Annual Review of Immunology, 2002
• The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses
  Annual Review of Immunology, 2002
• Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
  Nature Immunology, 2001
• Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment
  Expert Opinion on Biological Therapy, 2001
• Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness
  International Journal of Cancer, 2001
• Post-Transplant Malignancy
  Drug Safety, 2000